Experienced in Shingles

Amir S. Yazdi

Uniklinik RWTH Aachen
Aachen, NW, DE 
Experienced in Shingles
Uniklinik RWTH Aachen
Aachen, NW, DE 
OverviewLocationsClinical Research

Overview

Amir Yazdi practices in Aachen, Germany. Mr. Yazdi is rated as an Experienced expert by MediFind in the treatment of Shingles. His top areas of expertise are Pemphigus Foliaceus, Pemphigus, Pemphigus Vulgaris, and Bullae.

His clinical research consists of co-authoring 120 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 3 articles in the study of Shingles.

Gender
Male

Locations

Uniklinik RWTH Aachen
Aachen, NW, Germany
Other Locations
Tuebingen, BW, Germany

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Long-term Study to Assess the Safety and Efficacy of Lebrikizumab in Patients With Moderate-to-Severe Atopic Dermatitis (ADjoin)
A Long-term Study to Assess the Safety and Efficacy of Lebrikizumab in Patients With Moderate-to-Severe Atopic Dermatitis (ADjoin)
Enrollment Status: Completed
Publish Date: August 03, 2025
Intervention Type: Biological
Study Drug: Lebrikizumab
Study Phase: Phase 3
A Randomized, Double-blind, Placebo Controlled Trial to Evaluate the Efficacy and Safety of Lebrikizumab in Patients With Moderate to Severe Atopic Dermatitis.
A Randomized, Double-blind, Placebo Controlled Trial to Evaluate the Efficacy and Safety of Lebrikizumab in Patients With Moderate to Severe Atopic Dermatitis.
Enrollment Status: Completed
Publish Date: May 24, 2023
Intervention Type: Biological, Other
Study Drug: Lebrikizumab
Study Phase: Phase 3
View 1 Less Clinical Trial

120 Total Publications

Introducing human 3D skin models as a new serological diagnostic tool for severe autoimmune bullous diseases.
Introducing human 3D skin models as a new serological diagnostic tool for severe autoimmune bullous diseases.
Journal: Frontiers in immunology
Published: July 08, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Yazdi's expertise for a condition
ConditionClose
      View All 32 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile